Hologic Continues Spending Spree With $230M Tuck-In Acquisition Of Biotheranostics
Executive Summary
Hologic’s recent buy-outs put it in a strengthened growth and competitive position beyond COVID.
You may also be interested in...
Hologic Makes Good On Mobidiag Acquisition With Expanded Launch Of Diagnostics Platform
Following the purchase of Mobidiag, Hologic has aggressively launched the Novodiag platform across Europe in a bid to dominate the local molecular diagnostics market.
Hologic Continues 2021 Spending Spree With $795M Acquisition Of Mobidiag
Mobidiag develops molecular diagnostic tests and instrumentation that will expand Hologic’s acute care testing capabilities.
More IVD Mergers: Agilent Buys Resolution, Hologic Acquires Diagenode
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.